Oxford Spinout Wild Bioscience Receives £45 Million in Series A Funding from Ellison Institute of Technology
Wild Bioscience, a spinout from the University of Oxford, has secured an impressive £45 million in Series A funding led by Larry Ellison’s Ellison Institute of Technology. This funding will allow the company to further develop their AI-powered crop breeding platform and work towards creating climate-resilient crops to address the global issue of food security.
Founded in 2018 by a group of Oxford researchers, Wild Bioscience has made significant strides in the field of crop breeding. Their innovative platform uses artificial intelligence and machine learning to analyze and predict the genetic makeup of crops and identify the most desirable traits for breeding. This process not only saves time and resources but also increases the success rate of developing new and improved crop varieties.
The company’s mission to create climate-resilient crops is especially relevant in today’s world. With the growing global population and the threat of climate change, the need for sustainable and resilient food sources has become crucial. Wild Bioscience’s approach of using AI and data-driven technology to develop crops that can withstand extreme weather conditions and pests is a game-changer in the field of agriculture.
The backing of Ellison Institute of Technology, founded by the renowned entrepreneur and philanthropist Larry Ellison, is a significant endorsement for Wild Bioscience. With a strong focus on technology and innovation, the institute aims to support and invest in companies that are working towards solving global challenges. Their partnership with Wild Bioscience is a testament to the potential and impact of the company’s work.
In addition to funding, Ellison Institute of Technology will also provide valuable support and resources to Wild Bioscience. This includes access to the institute’s network of industry experts and mentors, as well as their state-of-the-art research facilities. With this support, Wild Bioscience will be able to accelerate their research and development efforts and bring their innovative solutions to the market faster.
The £45 million Series A funding round also saw participation from other investors, including Oxford Science Innovation and Amadeus Capital Partners. This further highlights the potential and promise of Wild Bioscience’s technology and the confidence that investors have in the company.
Professor Liam Dolan, founder of Wild Bioscience and Head of the Department of Plant Sciences at the University of Oxford, expressed his excitement about the partnership with Ellison Institute of Technology. He stated, “We are thrilled to have the support of Ellison Institute of Technology as we work towards our mission of creating climate-resilient crops. This partnership will not only provide us with the necessary funding but also invaluable expertise and resources to achieve our goals.”
The funding received by Wild Bioscience will be used to expand their team and further develop their AI-powered platform. With an increased focus on data analysis and machine learning, the company aims to enhance their crop breeding capabilities and create more sustainable and resilient crops.
In conclusion, the £45 million Series A funding round led by Ellison Institute of Technology is a significant milestone for Wild Bioscience. It not only provides the company with the necessary financial support but also validates the potential of their innovative technology. With this partnership, Wild Bioscience is well-positioned to make a positive impact on the global food security crisis and pave the way for a more sustainable and resilient future.
